A comprehensive single-cell RNA transcriptomic analysis identifies a unique SPP1+ macrophages subgroup in aging skeletal muscle

Sci Rep. 2024 Aug 6;14(1):18156. doi: 10.1038/s41598-024-69284-9.

Abstract

Senescence of skeletal muscle (SkM) has been a primary contributor to senior weakness and disability in recent years. The gradually declining SkM function associated with senescence has recently been connected to an imbalance between damage and repair. Macrophages (Mac) are involved in SkM aging, and different macrophage subgroups hold different biological functions. Through comprehensive single-cell transcriptomic analysis, we first compared the metabolic pathways and biological functions of different types of cells in young (Y) and old (O) mice SkM. Strikingly, the Mac population in mice SkM was also explored, and we identified a unique Mac subgroup in O SkM characterized by highly expressed SPP1 with strong senescence and adipogenesis features. Further work was carried out on the metabolic and biological processes for these Mac subgroups. Besides, we verified that the proportion of the SPP1+ Mac was increased significantly in the quadriceps tissues of O mice, and the senotherapeutic drug combination dasatinib + quercetin (D + Q) could dramatically reduce its proportion. Our study provides novel insight into the potential role of SPP1+ Mac in SkM, which may serve as a senotherapeutic target in SkM aging.

Keywords: Cell senescence; SPP1+ macrophages; Senolytics; Single-cell sequencing; Skeletal muscle.

MeSH terms

  • Adipogenesis / genetics
  • Aging* / genetics
  • Animals
  • Cellular Senescence / genetics
  • Dasatinib* / pharmacology
  • Gene Expression Profiling
  • Macrophages* / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Muscle, Skeletal* / metabolism
  • Quercetin / pharmacology
  • Senotherapeutics / pharmacology
  • Single-Cell Analysis*
  • Transcriptome*

Substances

  • Dasatinib
  • Quercetin
  • Senotherapeutics
  • Spp1 protein, mouse